Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Condition(s):Opioid-Related Disorders; Substance-Related Disorders; Narcotic-Related DisordersLast Updated:September 5, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Opioid-Related Disorders; Substance-Related Disorders; Narcotic-Related DisordersLast Updated:September 5, 2023Not yet recruiting
Condition(s):Opioid Use DisorderLast Updated:March 7, 2024Recruiting
Condition(s):Opioid-use DisorderLast Updated:August 14, 2023Recruiting
Condition(s):Opioid-use DisorderLast Updated:February 29, 2024Recruiting
Condition(s):Opioid Use DisorderLast Updated:February 22, 2024Recruiting
Condition(s):Opioid-use DisorderLast Updated:September 18, 2023Not yet recruiting
Condition(s):Moderate to Severe Opioid Use DisorderLast Updated:October 26, 2022Not yet recruiting
Condition(s):Drug Use; Opioid-use DisorderLast Updated:November 3, 2023Recruiting
Condition(s):Opioid Use DisorderLast Updated:October 7, 2022Recruiting
Condition(s):Opioid-use Disorder; HIV-1-infection; Immune Activation; Inflammation; Methadone; Buprenorphine; Naltrexone; Antiretroviral TreatmentLast Updated:July 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.